The main concerns in reproductive and developmental toxicity studies of human pharmaceuticals during the implementation of ICH M3 (R2) guidance

HUANG Fang-hua; WANG Qing-li; WANG Hai-xue; HAN Ling

doi:10.3969/j.issn.1003-3734.2020.01.004

Home>Articles>The main concerns in reproductive and developmental toxicity studies of human pharmaceuticals during the implementation of ICH M3 (R2) guidance

DOI: 10.3969/j.issn.1003-3734.2020.01.004

The main concerns in reproductive and developmental toxicity studies of human pharmaceuticals during the implementation of ICH M3 (R2) guidance

HUANG Fang-hua

WANG Qing-li

WANG Hai-xue

HAN Ling

Machine-generated Keywords：

Publication Date：2020-01-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：5( 22-26 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2020,29(1)